image
Recursion Pharmaceuticals, Inc. RXRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.175
-10.6 %
$ 1.73 B
Market Cap
-4.23
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 12.33% -37.02% -42.46%
Annual Report FY 10-K 2022-12-31 296.81% -34.45% -34.44%
Annual Report FY 10-K 2021-12-31 193.00% -102.63% -116.01%
Annual Report FY 10-K 2020-12-31 99.47% -40.55% -35.51%
Annual Report FY 10-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 158.19% -2.86% 1.20%
Quarterly Report Q2 8-K 2024-06-30 30.87% -27.13% -23.04%
Quarterly Report Q1 8-K 2024-03-31 13.68% -50.31% -37.89%
Quarterly Report Q4 8-K 2023-12-31 -20.36% -61.79% -78.95%
Quarterly Report Q3 8-K 2023-09-30 -22.61% -59.50% -59.09%
Quarterly Report Q2 8-K 2023-06-30 43.94% -17.06% -23.45%
Quarterly Report Q1 8-K 2023-03-31 128.99% -8.60% -24.80%
Quarterly Report Q4 8-K 2022-12-31 447.04% 11.48% 6.12%
Quarterly Report Q3 8-K 2022-09-30 422.12% -22.96% -34.85%
Quarterly Report Q2 8-K 2022-06-30 206.12% -51.02% -61.72%
Quarterly Report Q1 8-K 2022-03-31 111.96% -82.23% -83.64%
Quarterly Report Q4 8-K 2021-12-31 -2.00% -152.01% -153.94%
Quarterly Report Q3 8-K 2021-09-30 190.02% -98.67% -106.47%
Quarterly Report Q2 8-K 2021-06-30 1244.09% -129.11% -124.67%
Quarterly Report Q1 8-K 2021-03-31 4066.67% -66.72% -66.19%
Quarterly Report Q4 8-K 2020-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2020-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2020-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2020-03-31 0.00% 0.00% 0.00%